215 related articles for article (PubMed ID: 16011263)
41. Molecular modeling of histamine H3 receptor and QSAR studies on arylbenzofuran derived H3 antagonists.
Dastmalchi S; Hamzeh-Mivehroud M; Ghafourian T; Hamzeiy H
J Mol Graph Model; 2008 Jan; 26(5):834-44. PubMed ID: 17561422
[TBL] [Abstract][Full Text] [Related]
42. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.
Zhang Q; Yang J; Liang K; Feng L; Li S; Wan J; Xu X; Yang G; Liu D; Yang S
J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092
[TBL] [Abstract][Full Text] [Related]
43. LIV-3D-QSAR models for PGI2 receptor ligands using multiple conformations.
Azevedo Martins RC; Girão Albuquerque M; Bicca de Alencastro R
Eur J Med Chem; 2004 Apr; 39(4):359-67. PubMed ID: 15072844
[TBL] [Abstract][Full Text] [Related]
44. 3D QSAR studies of AChE inhibitors based on molecular docking scores and CoMFA.
Akula N; Lecanu L; Greeson J; Papadopoulos V
Bioorg Med Chem Lett; 2006 Dec; 16(24):6277-80. PubMed ID: 17049234
[TBL] [Abstract][Full Text] [Related]
45. What are the ideal properties for functional food peptides with antihypertensive effect? A computational peptidology approach.
Zhou P; Yang C; Ren Y; Wang C; Tian F
Food Chem; 2013 Dec; 141(3):2967-73. PubMed ID: 23871047
[TBL] [Abstract][Full Text] [Related]
46. Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function.
Schormann N; Senkovich O; Walker K; Wright DL; Anderson AC; Rosowsky A; Ananthan S; Shinkre B; Velu S; Chattopadhyay D
Proteins; 2008 Dec; 73(4):889-901. PubMed ID: 18536013
[TBL] [Abstract][Full Text] [Related]
47. Predicting the activity of ACE inhibitory peptides with a novel mode of pseudo amino acid composition.
Shu M; Cheng X; Zhang Y; Wang Y; Lin Y; Wang L; Lin Z
Protein Pept Lett; 2011 Dec; 18(12):1233-43. PubMed ID: 21728992
[TBL] [Abstract][Full Text] [Related]
48. A set of new amino acid descriptors applied in prediction of MHC class I binding peptides.
Liang G; Yang L; Chen Z; Mei H; Shu M; Li Z
Eur J Med Chem; 2009 Mar; 44(3):1144-54. PubMed ID: 18662841
[TBL] [Abstract][Full Text] [Related]
49. Short linear cationic antimicrobial peptides: screening, optimizing, and prediction.
Hilpert K; Fjell CD; Cherkasov A
Methods Mol Biol; 2008; 494():127-59. PubMed ID: 18726572
[TBL] [Abstract][Full Text] [Related]
50. Structure-activity relationship study of antioxidative peptides by QSAR modeling: the amino acid next to C-terminus affects the activity.
Li YW; Li B; He J; Qian P
J Pept Sci; 2011 Jun; 17(6):454-62. PubMed ID: 21491545
[TBL] [Abstract][Full Text] [Related]
51. On the physical interpretation of QSAR models.
Stanton DT
J Chem Inf Comput Sci; 2003; 43(5):1423-33. PubMed ID: 14502475
[TBL] [Abstract][Full Text] [Related]
52. Analysis of activity space by fragment fingerprints, 2D descriptors, and multitarget dependent transformation of 2D descriptors.
Givehchi A; Bender A; Glen RC
J Chem Inf Model; 2006; 46(3):1078-83. PubMed ID: 16711727
[TBL] [Abstract][Full Text] [Related]
53. Exploring molecular shape analysis of styrylquinoline derivatives as HIV-1 integrase inhibitors.
Leonard JT; Roy K
Eur J Med Chem; 2008 Jan; 43(1):81-92. PubMed ID: 17452064
[TBL] [Abstract][Full Text] [Related]
54. A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.
Sagardia I; Roa-Ureta RH; Bald C
Food Chem; 2013 Feb; 136(3-4):1370-6. PubMed ID: 23194537
[TBL] [Abstract][Full Text] [Related]
55. A molecular modeling and QSAR study of suppressors of the growth of Trypanosoma cruzi epimastigotes.
de Paula da Silva CH; Sanches SM; Taft CA
J Mol Graph Model; 2004 Sep; 23(1):89-97. PubMed ID: 15331057
[TBL] [Abstract][Full Text] [Related]
56. Antioxidant QSAR modeling as exemplified on polyphenols.
Lucić B; Amić D; Trinajstić N
Methods Mol Biol; 2008; 477():207-18. PubMed ID: 19082949
[TBL] [Abstract][Full Text] [Related]
57. Combined 3D-QSAR modeling and molecular docking study on indolinone derivatives as inhibitors of 3-phosphoinositide-dependent protein kinase-1.
AbdulHameed MD; Hamza A; Liu J; Zhan CG
J Chem Inf Model; 2008 Sep; 48(9):1760-72. PubMed ID: 18717540
[TBL] [Abstract][Full Text] [Related]
58. Gaussian process: an alternative approach for QSAM modeling of peptides.
Zhou P; Chen X; Wu Y; Shang Z
Amino Acids; 2010 Jan; 38(1):199-212. PubMed ID: 19123053
[TBL] [Abstract][Full Text] [Related]
59. Exploring QSAR for substituted 2-sulfonyl-phenyl-indol derivatives as potent and selective COX-2 inhibitors using different chemometrics tools.
Khoshneviszadeh M; Edraki N; Miri R; Hemmateenejad B
Chem Biol Drug Des; 2008 Dec; 72(6):564-74. PubMed ID: 19090923
[TBL] [Abstract][Full Text] [Related]
60. Molecule kernels: a descriptor- and alignment-free quantitative structure-activity relationship approach.
Mohr JA; Jain BJ; Obermayer K
J Chem Inf Model; 2008 Sep; 48(9):1868-81. PubMed ID: 18767832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
